Recognizing and improving health care disparities in the prevention of cardiovascular disease in women

Current Cardiology Reports

Volumn 12, Issue 6, 2010, Pages 488-496

  Jarvie, Jennifer L ^a   Foody, Joanne M ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Cardiovascular risk factors; Gender disparities; Prevention; Women

Indexed keywords

ACETYLSALICYLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

AGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL EFFECTIVENESS; CLINICAL STUDY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; HEALTH CARE DISPARITY; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; NICOTINE REPLACEMENT THERAPY; OBESITY; PATIENT CARE; PREDICTION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; REVIEW; RISK REDUCTION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WOMEN'S HEALTH;

AGE FACTORS; CARDIOVASCULAR DISEASES; CHOLESTEROL; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; MALE; OVERWEIGHT; RISK FACTORS; SEX FACTORS; SMOKING; TRIGLYCERIDES; UNITED STATES;

EID: 77958510289     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0135-4     Document Type: Review

References (50)

1. D Lloyd-Jones RJ Adams TM Brown, et al. 2010 Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 e1 e170 10.1161/CIRCULATIONAHA.109.878314
2. V Vaccarino L Parsons ED Peterson, et al. 2009 Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006 Arch Intern Med 169 1767 1774 10.1001/archinternmed.2009.332 19858434
3. C Daly F Clemens JL Sendon, et al. 2006 Gender differences in the management and clinical outcome of stable angina Circulation 113 490 498 10.1161/CIRCULATIONAHA.105.561647 16449728
4. L Mosca AH Linfante EJ Benjamin, et al. 2005 National study of physician awareness and adherence to cardiovascular disease prevention guidelines Circulation 111 499 510 10.1161/01.CIR.0000154568.43333.82 15687140 (Pubitemid 40204436)
5. M Heron DL Hoyert SL Murphy, et al. 2009 Deaths: final data for 2006 Natl Vital Stat Rep 57 1 134 19788058
6. P Jousilahti E Vartiainen J Tuomilehto, et al. 1999 Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up of 14, 786 middle-aged men and women in Finland Circulation 99 1165 1172 1:STN:280:DyaK1M7mvFSnsw%3D%3D 10069784
7. DT Ko M Mamdani DA Alter 2004 Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox JAMA 291 1864 1870 1:CAS:528:DC%2BD2cXjsVajsLs%3D 10.1001/jama.291.15.1864 15100205 (Pubitemid 38509499)
8. X Qiao KR McConnell RA Khalil 2008 Sex steroids and vascular responses in hypertension and aging Gend Med 5 Suppl A S46 S64 10.1016/j.genm.2008.03.006 18395683 (Pubitemid 351455231)
9. ME Mendelsohn 2000 Mechanisms of estrogen action in the cardiovascular system J Steroid Biochem Mol Biol 74 337 343 1:CAS:528:DC%2BD3MXitFyjtA%3D%3D 10.1016/S0960-0760(00)00110-2 11162942 (Pubitemid 32140406)
10. HU Irgens L Reisaeter LM Irgens, et al. 2001 Long term mortality of mothers and fathers after pre-eclampsia: population-based cohort study BMJ 323 1213 1217 1:STN:280:DC%2BD3MnntlSitw%3D%3D 10.1136/bmj.323.7323.1213 11719411
11. GC Smith JP Pell D Walsh 2001 Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129, 290 births Lancet 357 2002 2006 1:STN:280:DC%2BD3MzotVaitQ%3D%3D 10.1016/S0140-6736(00) 05112-6 11438131 (Pubitemid 32592386)
12. BD LeMarca J Gilbert JP Granger 2008 recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia Hypertension 51 982 988 10.1161/HYPERTENSIONAHA.107.108837 (Pubitemid 351398991)
13. JN Lubianca LB Moreira M Gus, et al. 2005 Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension J Hu Hypertens 19 451 455 1:STN:280:DC%2BD2M3mtFWrtg%3D%3D 10.1038/sj.jhh.1001841 (Pubitemid 40767180)
14. KA Matthews SL Crawford CU Chae, et al. 2009 Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 54 2366 2373 1:CAS:528:DC%2BC3cXhtFOmtbg%3D 10.1016/j.jacc.2009.10.009 20082925 This is a novel publication from the SWAN study looking specifically at cardiometabolic changes across the menopausal transition
15. WB Kannel 1987 Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study Am Heart J 114 413 419 1:STN:280:DyaL2s3mslakuw%3D%3D 10.1016/0002-8703(87)90511-4 3604900 (Pubitemid 17131737)
16. D Brunner J Weisbort N Meshulam, et al. 1987 Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study Am J Cardiol 59 1271 1276 1:STN:280:DyaL2s3jvVCguw%3D%3D 10.1016/0002-9149(87)90903-9 3591679 (Pubitemid 17093804)
17. O Lindquist C Bengtsson 1980 Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Goteborg, Sweden Scand J Clin Lab Invest 40 629 636 1:CAS:528:DyaL3MXhtlClsQ%3D%3D 10.3109/00365518009091974 7466291
18. O Lindquist 1982 Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: results from a prospective population study of women in Goteborg, Sweden Prev Med 11 162 172 1:STN:280:DyaL383it1SktA%3D%3D 10.1016/0091-7435(82)90015-9 7088904 (Pubitemid 12105254)
19. C Baigent A Keech PM Kearny, et al. 2005 Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins Lancet 366 1267 1278 1:CAS:528:DC%2BD2MXhtVOlu7fM 10.1016/S0140-6736(05)67394-1 16214597 (Pubitemid 41416582)
20. AD Sharrett CM Ballantyne SA Coady, et al. 2001 Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins a-I and B, and HDL density subfractions: the Atherosclerosis in Communities (ARIC) Study Circulation 104 1108 1113 1:CAS:528: DC%2BD3MXotlWgur0%3D 10.1161/hc3501.095214 11535564
21. Z Li JR McNamara JC Fruchart, et al. 1996 Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes J Lipid Res 37 1886 1896 1:CAS:528:DyaK28XlvVCktro%3D 8895054
22. V Zago S Sanguinetti F Brites, et al. 2004 Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women Atherosclerosis 177 203 210 1:CAS:528:DC%2BD2cXos1eku7k%3D 10.1016/j.atherosclerosis.2004.07. 011 15488885 (Pubitemid 39361157)
23. L Mosca LJ Appel EJ Benjamin, et al. 2004 Evidence-based guidelines for cardiovascular disease prevention in women Circulation 109 672 693 10.1161/01.CIR.0000114834.85476.81 14761900 (Pubitemid 38198877)
24. T Gordon WP Castelli MC Hjortland, et al. 1977 High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study Am J Med 62 707 714 1:CAS:528:DyaE2sXhvVOhtbg%3D 10.1016/0002-9343(77)90874-9 193398
25. DJ Gordon JL Probstfield RJ Garrison, et al. 1989 High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies Circulation 79 8 15 1:STN:280:DyaL1M%2FptVWjtg%3D%3D 2642759
26. MT Cooney A Dudina DD Bacquer, et al. 2009 HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk Atherosclerosis 206 611 616 1:CAS:528:DC%2BD1MXht1aju7fO 10.1016/j.atherosclerosis.2009.02.041 19375079 This is a recent publication looking at the role HDL plays in risk for CVD using pooled data from seven European prospective trials illustrating a stronger relationship between HDL and risk prediction in women compared with men
27. JE Hokanson MA Austin 1996 Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies J Cardiovasc Risk 3 213 219 1:STN:280:DyaK28vjtlyrtA%3D%3D 10.1097/00043798-199604000-00014 8836866
28. BG Nordestgaard M Benn P Schnohr, et al. 2007 Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 299 308 1:CAS:528:DC%2BD2sXotVWmsrk%3D 10.1001/jama.298.3.299 17635890 (Pubitemid 47080484)
29. AG Bostom DR Gagnon A Cupples, et al. 1994 A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women: the Framingham Heart Study Circulation 90 1688 1695 1:STN:280:DyaK2M%2FgvVSqsA%3D%3D 7923652
30. RP Bogers WJ Bemelmans RT Hoogenveen, et al. 2007 Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300, 000 persons Arch Intern Med 167 1720 1728 10.1001/archinte.167.16.1720 17846390 (Pubitemid 47403058)
31. R Bender KH Jockel C Trautner, et al. 1999 Effect of age on excess mortality in obesity JAMA 281 1498 1504 1:STN:280:DyaK1M3ktFymug%3D%3D 10.1001/jama.281.16.1498 10227319 (Pubitemid 29200933)
32. C Meisinger A Doring B Thorand, et al. 2006 Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The Monica/Kora Augsburg Cohort Study Am J Clin Nutr 84 483 489 1:CAS:528:DC%2BD28XpvVCqt7Y%3D 16960160
33. KF Adams A Schatzkin TB Harris, et al. 2006 Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old N Engl J Med 355 763 778 1:CAS:528:DC%2BD28Xos1Kmt70%3D 10.1056/NEJMoa055643 16926275 (Pubitemid 44285582)
34. PW Wilson RB D'Agnostino L Sullivan, et al. 2002 Overweight and obesity as determinants of cardiovascular risk: the Framingham experience Arch Intern Med 162 1867 1872 10.1001/archinte.162.16.1867 12196085
35. S Natarajan Y Liao G Cao, et al. 2003 Sex differences in risk of coronary heart disease mortality associated with diabetes and established coronary heart disease Arch Intern Med 163 1735 1740 10.1001/archinte.163.14.1735 12885690 (Pubitemid 36898963)
36. C Kim KM Newton RH Knopp 2002 Gestational diabetes and the incidence of type 2 diabetes: a systematic review Diabetes Care 25 1862 1868 10.2337/diacare.25.10.1862 12351492
37. AJ Lee RJ Hiscock P Wein, et al. 2007 Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes. a retrospective cohort study using survival analysis Diabetes Care 30 878 883 1:CAS:528:DC%2BD2sXkvVOgurc%3D 10.2337/dc06-1816 17392549 (Pubitemid 46556581)
38. JA Ambrose RS Barua 2004 The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol 43 1731 1737 1:CAS:528:DC%2BD2cXktVCms7k%3D 10.1016/j.jacc.2003.12.047 15145091 (Pubitemid 38622506)
39. DS Celermajer MR Adams P Clarkson, et al. 1996 passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults N Engl J Med 334 150 154 1:CAS:528:DyaK28Xos1GlsQ%3D%3D 10.1056/ NEJM199601183340303 8531969 (Pubitemid 26017952)
40. Pasupathi P, Bakthavathsalam G, Rao YY, et al.: Cigarette smoking-effect of metabolic health risk: a review. diabetes & metabolic syndrome: Clin Res Rev 2009, 3:120-127.
41. MV Zeman L Hiraki EM Sellers 2002 Gender differences in tobacco smoking: higher relative exposure to smoke than nicotine in women J Womens Health Gend Based Med 11 147 153 1:STN:280:DC%2BD383js12msQ%3D%3D 10.1089/152460902753645281 11975862 (Pubitemid 34296296)
42. A Bohadana F Nilsson T Rasmussen, et al. 2003 Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior Nicotine Tob Res 5 111 116 10.1080/ 1462220021000060482 12745512
43. A Cepeda-Benito JT Reynoso S Erath 2004 Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women J Consult Clin Psychol 72 712 722 10.1037/0022-006X.72.4.712 15301656 (Pubitemid 38988848)
44. Agency for Healthcare Research and Quality: Cardiovascular disease and other chronic conditions in women: recent findings. Program Brief. Available at http://www.ahrq.gov/research/womheart.htm. Accessed March 30, 2010.
45. AF Chou SH Scholle CS Weisman, et al. 2007 Gender disparities in the quality of cardiovascular disease care in private managed care plans Womens Health Issues 17 120 130 10.1016/j.whi.2007.03.002 17448685 (Pubitemid 46829859)
46. AF Chou L Wong CS Weisman, et al. 2007 Gender disparities in cardiovascular disease among commercial and medicare managed care plans Womens Health Issues 17 139 149 10.1016/j.whi.2007.03.004 17481918 (Pubitemid 46829860)
47. ES Ford AH Mokdad WH Giles, et al. 2003 Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000 Circulation 107 2185 2189 10.1161/01.CIR.0000066320.27195. B4 12719276 (Pubitemid 36547210)
48. S Mora RJ Glynn J Hsia, et al. 2010 Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials Circulation 121 1069 1077 1:CAS:528:DC%2BC3cXivV2ksLc%3D 10.1161/CIRCULATIONAHA.109.906479 20176986 This is a cutting-edge paper combining the results of the JUPITER trial's female participants with a meta-analysis of the role statins play in CVD prevention for women
49. AF Chou AF Brown RE Jensen, et al. 2007 Gender and racial disparities in the management of diabetes mellitus among medicare patients Womens Health Issues 17 150 161 10.1016/j.whi.2007.03.003 17475506 (Pubitemid 46829861)
50. DJ Wexler RW Grant JB Meigs, et al. 2005 Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes Diabetes Care 28 514 520 10.2337/diacare.28.3.514 15735180 (Pubitemid 40315306)